Lung Cancer Archives - Cancer Therapy Advisor

Experts acknowledged the growing importance of genomics to the field, but said more research is needed to justify changing current practices.

Researchers Propose Adding a Molecular Classifier to TNM Staging in Non-Small Cell Lung Cancer

By

January 16, 2020

Experts acknowledged the growing importance of genomics to the field, but said more research is needed to justify changing current practices.

“BRAF-mutated NSCLC represents an emerging targetable entity among the scenario of oncogene-driven N

Lung Cancer

Entrectinib Treatment May Eventually Be an Option for ROS1 Fusion-Positive NSCLC

By

Leah Lawrence

January 16, 2020

Disease control with entrectinib was found to be active and durable in ROS1 fusion-positive NSCLC.

Lung Cancer

Study Supports Standard-Dose RT in Chemoradiotherapy for Patients With Stage III Unresectable NSCLC

By

Susan Moench, PhD, PA-C

January 16, 2020

Long-term follow-up of the Radiation Therapy Oncology Group 0617 trial continues to support a 60-Gy radiation therapy dose as the standard of care.

Lung Cancer

Mutations in DNA Repair Pathway Genes Found to Be Prevalent in Mesothelioma

By

Leah Lawrence

January 15, 2020

Future studies should target gene members of these pathways.

Even though overall drug development times have not changed, questions about the clinical benefit of the drugs that have been approved through expedited pathways are being raised.

General Oncology

The FDA Approval Process Needs Refinement, Not a Total Overhaul

By

Randi Hernandez

January 14, 2020

Even though overall drug development times have not changed, questions about the clinical benefit of the drugs that have been approved through expedited pathways are being raised.

Platinum combination with pemetrexed resulted in better disease control and improved survival in pat

Lung Cancer

Staging Lung Adenocarcinoma: Study Finds No Support for Inclusion of Nodule Type in Clinical T Categories for Patients With Stage IA Disease

By

Susan Moench, PhD, PA-C

January 14, 2020

The results of this study support the recommendations for clinical T categorization from the eighth edition of the AJCC staging system for lung adenocarcinoma.